PLRX
PLRX
US7291391057
Pliant Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
63.16M EUR
70.59M EUR
78.01M EUR
74.97M EUR
Enterprise Value
-67.44M EUR
74.45M EUR
84.61M EUR
58.63M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-0.79x
--
--
--
Price to Sales
--
--
--
--
Price to Book
0.43x
0.48x
0.47x
0.41x
EV/Revenue
--
--
--
--
EV/EBITDA
0.75x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-67.3%
-100.43%
-126.66%
-106.16%
ende